This compound is a potent antiviral agent designed as a protease inhibitor targeting the NS3/4A protease enzyme, which plays a critical role in the replication cycle of the Hepatitis C virus (HCV). It prevents viral spread within the body, significantly reducing viral load in the bloodstream.

It is used as part of combination therapy for patients with chronic hepatitis C, often in conjunction with other agents such as NS5A inhibitors or other antivirals to improve treatment efficacy and minimize the risk of drug resistance.

Its complex structure enables precise target binding and high stability in the body, making it suitable for convenient oral administration with sustained blood levels sufficient for continuous viral inhibition.